- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/56 - One oxygen atom and one sulfur atom
Patent holdings for IPC class C07D 239/56
Total number of patents in this class: 108
10-year publication summary
|
7
|
9
|
12
|
6
|
8
|
3
|
9
|
8
|
4
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Kancera AB | 28 |
6 |
| Celgene Quanticel Research, Inc. | 155 |
5 |
| TES Pharma S.r.l. | 20 |
5 |
| Merck Sharp & Dohme LLC | 3734 |
5 |
| Pfizer Inc. | 3426 |
4 |
| Daiichi Sankyo Company, Limited | 1896 |
4 |
| Alkermes Pharma Ireland Limited | 254 |
3 |
| Corcept Therapeutics, Inc. | 373 |
3 |
| Hangzhou Adamerck Pharmlabs Inc. | 16 |
3 |
| Inflazome Limited | 84 |
3 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 245 |
3 |
| AstraZeneca AB | 2835 |
2 |
| Sumitomo Chemical Company, Limited | 8995 |
2 |
| Kunming Institute of Zoology, Chinese Academy of Sciences | 42 |
2 |
| Lek Pharmaceuticals d.d. | 180 |
2 |
| Memorial Sloan-Kettering Cancer Center | 2071 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4887 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 884 |
2 |
| Unimatec Co., Ltd. | 234 |
2 |
| Universidad de Granada | 314 |
2 |
| Other owners | 46 |